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introduction: Perineal hernia (PerH) following abdominoperineal excision (APE) proce-
dure is a recognized complication. PerH was considered an infrequent complication 
of APE procedure; however, PerH rates of up to 45% have been reported in recent 
publications following a laparoscopic APE procedure. Various methods of repair of PerH 
with the use of synthetic meshes or myocutaneous flap have been described, although 
there is no general agreement on an optimal strategy. The use of biological meshes for 
different operations is growing in popularity, and these have been promoted as being 
superior and safer when compared to synthetic meshes. Although the use of biologics is 
becoming popular claims of better outcomes are largely unsupported by evidence. The 
aim of this systematic review is to evaluate the currently available evidence supporting 
the use of biologic or biosynthetic meshes for the repair of PerH that develop following 
an APE.
Methods: A systematic review of all English language literature relevant to repair of 
PerH following APE with biologic or biosynthetic mesh published between January 1, 
2000 and July 31, 2016 was carried out using MEDLINE, EMBASE, and the Cochrane 
Library of Systematic Reviews for relevant literature. Searches were performed using 
a combination of Medical Subject Headings (MeSH) terms and text words “PerH,” 
“APE,” “morbidity,” “biologics,” “biosynthetic,” and “hernia.” Studies in which the use of 
biological meshes was not reported were excluded from the review. Various outcome 
measures, including operative technique, complication rates, recurrence rates, type of 
mesh, management of recurrences, and risk factors, were extracted. Oxford Centre for 
Evidence-based Medicine – Levels of Evidence (March 2009) was used to assess the 
quality of evidence.
Results: The systematic review of the literature identified three case reports, four case 
series, and one pooled analysis that were included in the final review. Overall, these 
studies were of poor quality providing level 4 evidence. Various different approaches 
and techniques of repair of PerH were described; however, it was difficult to extract 
information with regard to the primary and secondary outcome measures.
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Conclusion: There is no general agreement to the optimal operative strategy to repair 
PerH following an APE. There is insufficient evidence to recommend any specific opera-
tive approach or repair technique for PerH following an APE.
Keywords: perineal hernia, abdominoperineal excision, biologic mesh, biosynthetic mesh
iNTRODUCTiON
The finding of a perineal hernia (PerH) following an abdomin-
operineal excision (APE) is a recognized complication; however, 
it is unclear as to how frequently this occurs. Until a few years 
ago, they were considered to be an infrequent complication 
following an APE and prevalence rates of 0.6–7% were reported 
(1–6). However, the surgical management of rectal cancer has 
evolved over the recent years with the acceptance of the principle 
of total mesorectal excision (TME) and the recognition of the 
importance of a clear surgical resection and avoidance of tumor 
perforation during an APE (7). This procedure has evolved into 
the extra levator abdominoperineal excision (eLAPE) with the 
potential surgical resection margin information being identified 
through MRI staging (7, 8). This has resulted in a reduction in cir-
cumferential resection margin involvement and intra-operative 
perforation of the tumor (9). However, an eLAPE creates a wider 
defect in the pelvic floor leaving only the ischioanal fat and skin 
for closure of the defect as the entire pelvic floor muscle complex 
has been excised surrounding the distal rectum. Perineal her-
niation in this group of patients is increasingly recognized and a 
recent publication has reported an overall PerH rate of 26% and 
this can be as high as 45% in those having a laparoscopic eLAPE 
procedure (10).
A PerH repair may be necessary as the hernia is not only pain-
ful but can also result in urinary dysfunction or bowel obstruction 
causing impairment of daily activities of living. Various methods 
or repair have been described in the literature, including primary 
tissue repair, synthetic mesh, biological mesh, and myocutaneous 
flaps. This repair can be facilitated by either using an abdominal 
and/or perineal approach although none of the described repairs 
are well established.
The use of synthetic meshes is associated with problems, such 
as mesh infection, chronic inflammation, and foreign body reac-
tion. If bowel is in direct contact with the synthetic mesh used for 
a PerH repair, then there is a risk of adhesions and erosion into 
the bowel wall by the mesh. Biologic and biosynthetic meshes 
were developed to overcome such problems. The role of biologic 
mesh for primary reconstruction of the pelvic floor after eLAPE 
has been the subject of a systematic review, and this was consid-
ered a promising technique for improving wound healing and 
complication rates comparable to other techniques (11). Biologic 
meshes have been used recently as an alternative for repairing 
PerH following an eLAPE. The biologic mesh acts not only as 
a structural support for the hernia repair but also as a scaffold 
allowing the ingrowth of native fibroblasts, which in turn lay 
down the fibrous tissue and promote tissue remodeling (12). The 
aim of this systematic review is to evaluate the currently available 
evidence supporting the use of biologic or biosynthetic meshes 
for the repair of PerH.
MeTHODS
Search Strategy
A systematic review of all English language literature relevant to 
the repair of a PerH following an APE with biologic or biosyn-
thetic mesh published between January 1, 2000 and July 31, 2016 
was carried out using MEDLINE (PubMed and Ovid), EMBASE 
(Ovid), and the Cochrane Library of Systematic Reviews/
Controlled Trials for relevant literature. Searches were performed 
using a combination of Medical Subject Headings (MeSH) terms 
and text words “perineal hernia,” “abdominoperineal excision,” 
“morbidity,” “biologics,” “biosynthetic,” and “hernia.” All rand-
omized/non-randomized, controlled/non-controlled clinical 
trials, prospective observational studies, clinical registry data, 
retrospective case series, and case reports that reported on repair 
of PerH following APE were included for analysis. Conference 
abstracts, letters, technical notes, and commentaries were 
excluded. In addition, bibliographies from the papers requested 
were manually checked to identify additional relevant papers.
Study Selection
Titles and abstracts of the identified studies were screened by the 
main reviewer Sunil K. Narang and independently checked by 
Nasra N. Alam. Studies that were irrelevant were rejected. The 
full texts of identified papers were independently assessed by two 
reviewers (Sunil K. Narang and Nasra N. Alam) to determine 
whether they met the predetermined inclusion/exclusion criteria. 
Disagreements were resolved by discussion or adjudication by the 
senior author (Neil J. Smart).
inclusion Criteria
All studies should have been published in print or electronic 
format between 1 January, 2000 and July 31, 2016. Only adult 
patients undergoing PerH repair following APE were included in 
the review. An APE may have been performed as an open proce-
dure, laparoscopic, hand-assisted or robot-assisted. PerH repair 
may have been done using open, laparoscopic, or combined 
approach. The diagnosis of PerH may have been established based 
on clinical examination or cross-sectional imaging.
exclusion Criteria
Studies on the pediatric population or using synthetic mesh or 
myocutaneous flaps were excluded from this review. Diagnosis 
of PerH established on the basis of patient-reported symptoms 
of PerH or telephone or postal follow-up were excluded from the 
review.
Outcomes
The primary outcome measure of the systematic review was 
to assess the recurrence of PerH following repair with biologic 
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or biosynthetic meshes. Other factors, such as time interval to 
development of PerH and diagnostic definition of PerH (clinical, 
cross-sectional imaging, patient-reported or telephone inter-
view), were also noted.
The secondary outcome measures recorded were:
 1. Complications following repair.
 2. Management of recurrences.
 3. Patient-reported outcome measures or quality of life scores.
Definitions
Clinically, a PerH is defined as a palpable bulge in the perineum 
associated with protrusion of intra-abdominal or pelvic viscera 
through the defect in the pelvic floor fascia and musculature. 
Radiographic definition of PerH unclear as the landmarks for 
defining the pelvic floor are not universally agreed.
Quality Assessment
Oxford Centre for Evidence-based Medicine – Levels of Evidence 
(March 2009) was used to assess the quality of evidence (13).
Data extraction (Selection and Coding)
Data on the study type, number of patients treated, length of 
follow-up, cross-sectional imaging, and symptoms from PerH 
were extracted from the included studies by the reviewers. These 
data were extracted separately by reviewers (Sunil K. Narang and 
Nasra N. Alam) to guard against reviewer bias. Any  discrepancies 
were resolved by adjudication by the senior author Neil J. Smart. 
All data and results of statistical tests were extracted from the 
papers and entered into an electronic data sheet (Microsoft 
Excel). For particular outcomes that were to be evaluated, if the 
data were not specifically reported, they were regarded as not 
reported or missing and no assumptions were made regarding 
the missing data.
Statistical Analysis
There was a significant heterogeneity in the included studies in 
the study design, intervention design, study cohorts, and out-
come measures. A weighted analysis of variables for risk factors 
for PerH development was not possible because of the lack of 
both uniformity and the quantity of the data reported. For this 
reason, a meta-analysis of the data could not be performed; 
therefore, primary and secondary outcome measure parameters 
are expressed as a range.
ReSULTS
A total of 190 potential articles were identified from the initial 
literature search. After removal of duplicate articles 176 articles 
remained (Figure 1). Using the inclusion criteria described above, 
146 articles were eliminated on title and abstract review. Full text 
articles were obtained for 30 articles out of which 22 articles were 
rejected, as they did not meet the inclusion criteria. Eight articles 
were included for final analysis. Out of the eight articles that 
were included, three were case reports, four were case series, and 
one article was a pooled analysis. The quality assessment of the 
included studies is presented in Tables 1–3. The level of evidence 
based on the Oxford Centre for Evidence-based Medicine (March 
2009) was 4 at best. The pooled analysis included all publications 
from 1944 to 2010 and has probably included data from Skipworth 
et al. (14) and de Campos et al. (15). There was a significant vari-
ation among studies in their description of diagnostic method, 
selection criteria, operative technique, type of mesh used, and 
duration of follow-up, recurrence rates, complications, and man-
agement of recurrences. None of the studies in the review used 
the Clavien Dindo grading of post-operative complications (16).
In the three case reports, there were no recurrences following 
repair of PerH on follow-up ranging from 12 to 18 months (11, 
13, 14). Of the four case series, the duration of follow-up and 
final outcome was not reported in one publication (4, 8, 12). 
In the remaining three case series, different types of cross and 
non-cross-linked biologic meshes were used and some patients 
underwent myocutaneous flap repair and/or omentoplasy in 
addition to the mesh repair.
The operative technique to repair a PerH varied significantly 
ranging from perineal repair, open abdominal repair, or com-
bined approach with or without the use of laparoscope. The 
type of biological mesh used was not reported in three studies. 
Others described the use of additionally cross-linked acellular 
porcine collagen (Permacol™), non-cross-linked porcine col-
lagen (Strattice™), Human-derived Acellular Dermal graft 
(DermaMatrix), Dura mater patch, and Bovine pericardium. 
Complications following repair were not reported in any of the 
case reports although the pooled analysis reported a perineal 
wound breakdown rate of 12% with the use of all different types 
of synthetic and biologic meshes. Management of recurrence of 
PerH was reported by Musters et  al. and four recurrent PerH 
were repaired using prolene mesh (19). None of the studies 
used patient-reported outcome measures to assess the impact of 
surgery on the quality of life of the patients.
DiSCUSSiON
A PerH is an incisional hernia through the pelvic floor, which 
results in protrusion of abdominal or pelvic viscera. There is 
no universally accepted clinical or radiological definition of a 
PerH. They are typically diagnosed based on symptoms, such as 
an expansile cough impulse in the perineum, which is not only 
uncomfortable but can also cause bowel or bladder symptoms. In 
the majority of cases, this hernia remains asymptomatic and may 
be incidentally detected on cross-sectional imaging performed 
for oncologic follow-up. It is vital that there should be a univer-
sally agreed clinical and radiological definition of PerH in order 
to make meaningful comparison between studies.
Most publications reporting PerH repair following APE are 
either individual case reports or small retrospective case series 
with relatively short follow-up. This review includes mostly 
small case series over a long period of time reporting different 
techniques performed by different surgeons. These papers are 
focused on the description of successful technique and are, 
therefore, prone to publication bias. It appears that myocutaneous 
flap techniques have a role in repair of PerH when the operative 
field has been severely damaged by irradiation and can provide 
TABLe 1 | Case reports.
Reference n Study 
period
M:F Age 
(years)
Treatment 
of primary 
disease
Approach to perineal  
hernia repair
Mesh type Follow-up Outcome Complications
Ong and 
Miller (17)
1 12 months 
after APR
72 Neoadjuvant 
CRT
Transperineal using Mitek suture 
anchors
Acellular porcine dermal 
mesh (Permacol) 
6 months No recurrence Nil
Kathju 
et al. (18)
1 2011 M 56 Neoadjuvant 
CRT, APR
Abdominoperineal Human-derived acellular 
dermal graft (Derma 
Matrix)
1 year No 
complications 
or recurrence
NR
Mesh anchored anteriorly to 
pubic bone using Mitek suture 
anchors
Skipworth 
et al. (14)
1 2006 M 46 Pre op CRT Perineal approach Porcine collagen matrix 18 months No recurrence NR
Trendelenburg lithotomy positon
FiGURe 1 | PRiSMA flow diagram outlining study selection.
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a well-vascularized tissue for repair (19, 22). None of the studies 
compared the use of biologics with either prosthetic mesh or 
myocutaneous flaps and, therefore, findings of individual studies 
are difficult to interpret.
Some of the risk factors that may predispose an individual 
to the development of PerH include female gender, previous 
hysterectomy, coccygectomy, pre-operative pelvic irradiation, 
post-operative wound infection, a long small bowel mesentery, 
high BMI, smoking, and non-closure of the pelvic peritoneum 
(1, 6, 21, 23, 24). Patients with rectal cancer may have been treated 
with neoadjuvant chemoradiotherapy. The role of these risk fac-
tors has not been evaluated in these studies.
TABLe 2 | Case series.
Reference n Study period M:F Age Treatment of  
primary disease
Approach to perineal  
hernia repair
Mesh type Follow-up Outcome Complications
Musters  
et al. (19)
15 50 months 9:6 62 ± 11 years 
mean
Conventional APR (n, %) 
5 (33)
Transperineal 14
Laparoscopic Omental 
plasty + Transperinal 1
Permacol™ 3 17 months 
median  
(IQR 12–24)
Clinical recurrence 
7 (47%)
Wound infection  
3 patientsStrattice™ 12
Extralevator APR (n, %) 
5 (33)
Myocutaneous 
flap + Biological 
mesh 3Ischio-anal APR (n, %) 4 (27)
Intersphincteric APR  
(n, %) 1 (7)
Sayers  
et al. (10)
14/54 54 months 40:14 69.5 years median 
(31–90)
eLAPE 20 Not reported Biologic mesh 5/8
Myocutaneous 
flap 3/8
57.5 months, 
median 
(29–61)
Biologic mesh, 1/5 
had recurrence
Myocutaneous flap, 
1/3 had recurrence
NR
Neo-CRT 52
Biological mesh 2
Myocutaneous flap  
6 (5 rectus and 1 gracilis)
Simple suture in 46
Abbas and 
Garner (20)
7 Over 66 months 4:3 64 years median 
(44–77)
0.5 after lap APER
1 had gluteal rotation flap
All had RT
1 had adjuvant CT
Lap repair 5
Lap converted to open 1
Perineal approach 1 (sublay)
Synthetic 
composite 4
Biological 2
Direct suture 
repair 1
25 months 
(16–64)
No recurrences NR
de Campos 
et al. (15)
7 1995–2004 NR NR 35 patients in one center 
had pre op CT. 4/35 
developed PERH
3 patients from another 
center
Dura mater patch 
via laparotomy 1
Bovine pericardium 
1 via perineal 
approach
Bovine pericardium 
via abdominal 
approach 1
Conservative 1
NR NR NR
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The decision to repair PerH is based on the symptoms, fitness 
of the patient and oncological stage. Repair may be performed 
via abdominal, perineal, or combined approach. Laparoscopy has 
been used in patients with reasonable access. There is no evidence 
to support the use of any particular approach. The pooled analysis 
by Mjoli et al. reported 22 perineal repairs, 11 open abdominal 
operations, 3 combined abdominoperineal approach, 5 laparo-
scopic repairs, and 2 laparoscopic-perineal procedures (21).
Within the last decade, the eLAPE procedure has become 
increasing popular and has led to reduction in the circumferential 
margin positivity rate. However, due to the wider resection of the 
pelvic floor, the risk of herniation may be higher. The pelvic floor 
may or may not have been reconstructed using flaps/meshes, etc. 
There is evidence that laparoscopy results in fewer adhesion in the 
abdomen and this may contribute to increasing PerH rates as the 
small and large bowel are free to descend into the pelvis (25, 26). 
It is likely that the incidence and prevalence of PerH will increase 
unless there is a much better technique of primary reconstruction 
of the pelvic floor at the time of APE.
The advent of synthetic absorbable meshes has generated 
considerable interest within the surgical community. These 
materials promote fibroblast activity and generate a foreign body 
reaction. Following complete absorption within 30–90 days, the 
synthetic material is replaced by collagen rich connective tissue. 
In this review, only one patient was identified to have undergone 
repair with an absorbable mesh and this hernia recurred within 
16  months (21). The use of biologic mesh for repairing PerH 
appears attractive as the acellular collagen matrix is believed to 
allow migration of fibroblasts, neovascularization, and incor-
poration within the native tissues. This is thought to reduce the 
risk of wound infection. A recently published case series of 15 
patients undergoing PerH repair with porcine acellular dermal 
mesh reported recurrence rates of 47% after a median follow-up 
of 17 months (IQR 12–24) (19). However, the low volume, qual-
ity of available data, and lack of any comparative studies make 
it difficult to evaluate the use of biologic meshes as a technique.
CONCLUSiON
There is no general agreement to the optimal operative strategy 
to repair PerH following an APE. There is insufficient evidence to 
recommend any specific operative approach or repair technique 
for PerH following APE.
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BioMesh Study Group
Ferdinand Köckerling (Chairman), Stavros Antoniou, René 
Fortelny, Frank A. Granderath, Markus Heiss, Franz Mayer, Marc 
Miserez, Agneta Montgomery, Salvador Morales-Conde, Filip 
Muysoms, Alexander Petter-Puchner, Rudolph Pointner, Neil 
Smart, Marciej Smietanski, Bernd Stechemesser.
Aim
The BioMesh Study Group has set itself the task of iden-
tifying how best to use biological meshes for the various 
indications. The first step toward achieving that goal is to 
compile systematic reviews of the different indications on the 
basis of the existing literature. The available literature sources 
will be evaluated in accordance with the Oxford Centre for 
Evidence-based Medicine-Levels of Evidence (March 2009). 
Next, based on the review findings, corresponding Statements 
and Recommendations are to be formulated in a Consensus 
Conference for the use of biological meshes for the different 
indications. The findings of this study were presented at the 
Consensus Conference in Berlin in January 2016 as a part of the 
project undertaken by the BioMesh Study Group. The findings 
of the Consensus Conference are currently being summarized 
for a joint publication.
